EHS
EHS

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for…
EHS
Back to top button